Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6001562 | Thrombosis Research | 2015 | 9 Pages |
Abstract
STA®-Staclot®DRVV-Confirm provides a rapid estimation of the intensity of anticoagulation with rivaroxaban or dabigatran without specific calibrators. At Ctrough, thresholds for rivaroxaban and dabigatran can be used to identify supra-therapeutic plasma level. However, this test cannot differentiate the nature of the NOACs. The development of a point-of-care device optimising this method would be of particular interest in emergency situations.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jonathan Douxfils, Bernard Chatelain, Paul Hjemdahl, Bérangère Devalet, Anne-Laure Sennesael, Pierre Wallemacq, Yuko Rönquist-Nii, Anton Pohanka, Jean-Michel Dogné, François Mullier,